5-{3-[4-(4-Methyl-benzyl)-piperidin-1-yl]-prop-1-ynyl}-1,3-dihydro-benzoimidazol-2-one

ID: ALA419399

PubChem CID: 10689828

Max Phase: Preclinical

Molecular Formula: C23H25N3O

Molecular Weight: 359.47

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(CC2CCN(CC#Cc3ccc4[nH]c(O)nc4c3)CC2)cc1

Standard InChI:  InChI=1S/C23H25N3O/c1-17-4-6-19(7-5-17)15-20-10-13-26(14-11-20)12-2-3-18-8-9-21-22(16-18)25-23(27)24-21/h4-9,16,20H,10-15H2,1H3,(H2,24,25,27)

Standard InChI Key:  LHUVDZHUMLCYFE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   11.4417   -2.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8417   -1.6667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.0792   -2.9792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1125   -2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2625   -2.8750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1417   -1.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9250   -2.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7250   -1.9750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2667   -2.2417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.3417   -1.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7042   -2.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6250   -3.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3542   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9542   -1.6792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8625   -2.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0250   -3.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8000   -3.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8500   -3.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4625   -2.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4500   -3.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3792   -3.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8917   -2.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6042   -3.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1167   -2.1292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3125   -2.2042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2250   -3.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6875   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  2  1  0
  5  3  1  0
  6  7  3  0
  7 11  1  0
  8 13  1  0
  9  1  1  0
 10  4  2  0
 11 10  1  0
 12  5  2  0
 13  6  1  0
 14  8  1  0
 15  8  1  0
 16 17  1  0
 17 20  1  0
 18 12  1  0
 19 24  2  0
 20 26  1  0
 21 16  1  0
 22 16  2  0
 23 21  2  0
 24 22  1  0
 25 14  1  0
 26 15  1  0
 27 19  1  0
  5  4  1  0
 11 18  2  0
 25 20  1  0
 19 23  1  0
M  END

Associated Targets(Human)

GRIN1 Tclin Glutamate (NMDA) receptor subunit zeta 1 (122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Grin2c Glutamate [NMDA] receptor subunit epsilon 3 (367 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Adrenergic receptor alpha-1 (5652 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Drd2 Dopamine D2 receptor (7893 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 359.47Molecular Weight (Monoisotopic): 359.1998AlogP: 3.88#Rotatable Bonds: 3
Polar Surface Area: 52.15Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.47CX Basic pKa: 8.02CX LogP: 5.12CX LogD: 4.56
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.70Np Likeness Score: -0.88

References

1. Wright JL, Gregory TF, Kesten SR, Boxer PA, Serpa KA, Meltzer LT, Wise LD, Espitia SA, Konkoy CS, Whittemore ER, Woodward RM..  (2000)  Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(heteroarylalkynyl)-4-benzylpiperidines.,  43  (18): [PMID:10978188] [10.1021/jm000023o]

Source